Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Am J Prev Med. 2020 Nov 7;60(2):e85–e94. doi: 10.1016/j.amepre.2020.08.029

Table 2.

Summary of the Strategy Reach (N=16)

Reference Genetic risk screening reach (n=13) Genetic counseling service reach (n=10)
Number of individuals who completed genetic risk screening (Numerator) Number of individuals who could have been screened (Denominator) Screening reach (%) Number of individuals who completed genetic counseling (Numerator) Number of individuals found to be eligible for genetic counseling (Denominator) Counseling reach (%)
Clinical settings
 General practice
  Scheuner (2014) 1,275 2,321 55% 104 166 63%
  Anderson (2015) 237 448 53% NA NA NA
  Bradbury (2016) 82 100 82% 61 100 61%
  Helsper (2018) 30 30 100% 5 19 26%
 Community screening mammography practice
  Lee (2005) 7,316 NA NA 74 280 26%
  Seymour (2008) NA NA NA NA 707 NA
  Wernke (2019) 126 1,169 11% 4 35 11%
  McGuinness (2019) 3,055 18,502 17% NA NA NA
 Community gastroenterology practice
  Gunaratnam (2016) 6,031 6,031 100% 7 848 1%
  Luba (2018) 3,134 5,287 59% 177 NA NA
 Multiple clinics (e.g., mammography center, ambulatory clinics)
  Lieberman (2017) 1,771 NA NA 1,771 1,771 100%
Public health settings
 Healthcare call center
  Miller (2005) 279 492 57% NA NA NA
  Pasick (2016) 709 1,212 58% 30 44 68%
 Population-based cancer registry
  Lowery (2010) 181 575 31% 20 181 11%
  Niendorf (2016) 869 1,992 44% 500 769 65%
 Unclear community setting
  Vanags (2010) 18,642 24,210 77% NA NA NA

NA, not available.